Background
The role of aldehyde dehydrogenase 2 (ALDH2) in cardiovascular diseases has been gradually studied. However, it is unclear whether
ALDH2
polymorphism is associated with the risk of early onset (onset age ≤55 years old in men and ≤65 years old in women) coronary artery stenosis (CAS). The association between
ALDH2
single nucleotide polymorphism (SNP) rs671 and risk in patients with early onset CAS was investigated in this study.
Methods
The study included 213 early onset CAS patients and 352 individuals without CAS were set as controls. The
ALDH2
rs671 polymorphism was genotyped by polymerase chain reaction (PCR) - microarray. Differences in
ALDH2
rs671 genotypes and alleles between patients and controls were compared. Multiple logistic regression analysis was performed after adjusting for gender, body mass index (BMI), smoking history, drinking history, and diabetes mellitus to assess the relationship between
ALDH2
rs671 genotypes and early onset CAS risk.
Results
The frequency of the
ALDH2
rs671 G/G genotype was lower in the early onset CAS patients (43.7% vs 55.3%,
p
=0.007) than that in the controls. The frequency of the
ALDH2
rs671 A allele was higher (32.9% vs 25.0%) than that in the controls (
p
=0.005). After adjusting for other confounding factors, multivariate logistic regression showed that
ALDH2
rs671 A/A genotype (A/A vs G/G: odds ratio (OR) 2.508, 95% confidence interval (CI): 1.130–5.569,
p
=0.024), overweight (BMI≥24.0 vs 18.5–23.9: OR 5.047, 95% CI: 3.275–7.777,
p
<0.001), history of smoking (yes vs no: OR 2.813, 95% CI: 1.595–4.961,
p
<0.001), and diabetes mellitus (yes vs no: OR 2.191, 95% CI: 1.397–3.437,
p
=0.001) were the independent risk factors of early onset CAS.
Conclusion
In men ≤55 years old and women ≤65 years old, individuals with
ALDH2
rs671 A/A genotype, overweight (BMI ≥24.0 kg/m
2
), smoking history, and diabetes mellitus increased risk of developing CAS.